Novel Combination Therapy Offers Hope for Immunotherapy-Resistant Aggressive Lymphoma
In a groundbreaking advancement for the treatment of relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL), researchers have unveiled a ...
In a groundbreaking advancement for the treatment of relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL), researchers have unveiled a ...
Cancer immunotherapy has revolutionized the treatment landscape for several malignancies by mobilizing the adaptive immune system, particularly T cells, to ...
In the relentless battle against breast cancer, researchers have long sought to understand the elusive mechanisms that fuel tumor resilience ...
For nearly 40 years, erythropoietin (EPO) has been recognized primarily for its role in stimulating red blood cell production, a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine